YK

Yogaathipathy Kandasamy

Director Director DIN 09409541
DIN 09409541 First appointment Nov 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Nov 2021
Shareholding value •••• Premium profile

About Yogaathipathy Kandasamy

Data last updated:

Yogaathipathy Kandasamy was a Director at Sreeva Hospital Private Limited (2021–2022) and Director at Sreeva Pharma Private Limited (2021–2022). The companies operate in Healthcare and Pharma.

DIN 09409541
Primary Designation Director
Industry Healthcare
First Appointment 23 Nov 2021

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sreeva Hospital Private Limited U85300KA2021PTC154891
Director26 Nov 20212021Active
Sreeva Pharma Private Limited U85190KA2021PTC154734
Director23 Nov 20212021Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sreeva Hospital Private Limited
Sreeva Pharma Private Limited
Premium access

Shareholding and investment profile for Yogaathipathy Kandasamy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yogaathipathy Kandasamy

Yogaathipathy Kandasamy was first appointed on 23 Nov 2021 as Director at Sreeva Pharma Private Limited.

Yogaathipathy Kandasamy held 2 earlier board appointments: Sreeva Hospital Private Limited (Director, 26 Nov 2021 to 23 Feb 2022); Sreeva Pharma Private Limited (Director, 23 Nov 2021 to 23 Feb 2022).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available